drugset / Trial / NCT03550859
HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is to evaluate the renal function of HMG-CoA reductase add-on in chronic kidney disease patients with proteinuria.
Timeline
- Start
- 2018-06-05
- Primary completion
- 2021-12
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 10 mg | — |
| Comparator | Telmisartan | Other / unclassified | 40 mg | — |